GILD

Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.

SeekingAlpha · 1d ago

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

Benzinga · 3d ago

Gilead Sciences is rated Sell, with a $97.46 fair value versus the $150.56 closing price, implying 35.3% downside. Click for more on the GILD stock.

SeekingAlpha · 4d ago

Gilead Sciences (GILD) closed the most recent trading day at $152.67, moving +1.4% from the previous trading session.

Yahoo · 4d ago

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Yahoo · 5d ago

Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.

CNBC · 5d ago

Bristol Myers' growth portfolio and pipeline advances offer multiple ways to offset legacy-product erosion, while valuation and leverage remain key factors.

Yahoo · 6d ago